Latest Breaking News On - Caristo diagnostics - Page 4 : comparemela.com

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

This 32-country randomized clinical trial assesses the effects of bempedoic acid on cardiovascular outcomes in statin-intolerant patients receiving bempedoic ac

United statesEli lillyDanielle brennanBitteroot bioElucid bioimagingTensixteen bioEulicid bioimagingStevene nissenBecton dicksonDaiichi sankyoMedicines companyClinical researchGordy healthHealth outlookDalcor pharmaceuticalsAmerican diabetes association scientific sessions

Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular Disease

Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomKeith channonCharalambos antoniadesHeart analysis serviceBritish heart foundation professor of cardiovascular medicineDrug administrationPrnewswire caristo diagnosticsCardiovascular researchCaristo diagnosticsUniversity of oxfordApproval heightensDiagnostics limitedUnited statesProfessor charalambos antoniadesCaristo diagnostics chief scientific officerBritish heart foundation professor

Brainomix Expands its UK Headquarters with New Facilities in Oxford

/PRNewswire/ Brainomix, the AI-powered medtech solutions company, today announced it has moved to a new head office in Oxford, located in the landmark.

United statesUnited kingdomJeff wyrtzenLaura harrisSerena rianjongdeeMichalis papadakisPrnewswire brainomixSue charlesUniversity of oxfordOxford university innovationMarketing business developmentSeacourt towerCrown interiorsBotley business parkMirada medicalCaristo diagnostics

Caristo Diagnostics Completes US$16 3M Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Frank chengUniversity of oxfordOxford universityOxford investment consultantsOxford science enterprisesCaristo diagnosticsUnited kingdom basedLongwall venture partnersFat attenuation index

Caristo Diagnostics Completes Series A Financing and Welcomes New CEO to Advance Ground-Breaking AI Technology for Cardiac Disease Detection

$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ Caristo Diagnostics Limited, a global

United kingdomFrank chengOran mudurogluHeather roxboroughEyenuk incUniversity of oxfordPrnewswire caristo diagnosticsHead of healthtech at oxford science enterprisesHealth techOxford investment consultantsLife sciencesCaristo diagnosticsOxford science enterprisesOxford universityCardiovascular researchHeart analysis service